Randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks

Completed

Phase N/A Results

Eligibility Criteria

Inclusion Criteria

Hospitalized patients who had experienced at least one TIA within 7 days of admission, 18-85 years of age.

Exclusion Criteria

Focal deficits lasting > 24 hours, intracranial hemorrhages or active bleeding, intracranial aneurysm visualized on baseline computed tomography (CT), sustained calculated mean arterial blood pressure > 140/90 mm Hg, elevated partial thromboplastin times (PTTs), elevated prothrombin times (PTs), platelet counts < 125,000/mm, renal insufficiency, active hepatic disease, pregnant women, active collagen-vascular disease, known hypersensitivity or other adverse reaction to heparin or aspirin.